Intest Stock Price, News & Analysis

inTEST Corporation (NYSE American: INTT) reported record fourth quarter revenue of $32.4 million, a 45% increase, and full year revenue of $116.8 million, up 38% compared to the prior year. Fourth quarter earnings per diluted share were $0.30, with $31.3 million in orders, marking a 3% increase. The company anticipates Q1 2023 revenue between $30 million and $32 million, and full year 2023 revenue of $125 million to $130 million. The growth was supported by strong demand in semiconductor, automotive, defense, and life sciences sectors, alongside successful integration of acquisitions.

inTEST Corporation (NYSE American: INTT) reported preliminary unaudited results for Q4 and FY 2022, highlighting a substantial revenue growth. Q4 revenue is anticipated at $32.4 million, up 44.9% from Q4 2021, while total revenue for 2022 is projected at $116.8 million, indicating a 37.6% year-over-year increase. Orders for Q4 were approximately $31.3 million, a 2.8% rise compared to the previous year, with full-year orders reaching $129.6 million, marking a 27.1% increase. CEO Nick Grant expressed optimism regarding demand and future growth strategies. A detailed earnings report is expected on March 3, 2023.

inTEST Corporation (NYSE American: INTT), a leader in innovative test and process solutions, announced participation in the Allied Global Partners Tech Conference on February 16. The company’s President & CEO, Nick Grant, and CFO, Duncan Gilmour, will be available for investor meetings. inTEST operates across diverse sectors including automotive, defense, industrial, life sciences, and semiconductor manufacturing, leveraging extensive engineering expertise to solve complex challenges. With a focus on organic growth and acquisitions, inTEST aims to expand its market reach and innovative technologies.

inTEST Corporation (NYSE American: INTT) has partnered with Traceable, an Antylia Scientific Company, to integrate its TraceableLIVE® cloud service into North Sciences Ultra-Low Temperature (ULT) biomedical freezers. This addition will enable remote monitoring of critical temperatures, enhancing sample security for medical and research labs. The freezers, capable of -86°C storage, are designed to protect samples and research integrity. This collaboration aims to provide a modern solution for researchers, ensuring peace of mind regarding sample safety.

inTEST Corporation (NYSE American: INTT) announced that President & CEO Nick Grant and CFO Duncan Gilmour will present at the Southwest IDEAS Conference in Dallas, TX on November 16, 2022, at 11:00 a.m. Central Time. The event will be webcast live, and a replay will be available on the company's investor relations website. inTEST is known for providing innovative test and process solutions across several key markets, including automotive, aerospace, and semiconductor manufacturing, driven by their engineering expertise and operational excellence.

inTEST Corporation reported record revenue for the second consecutive quarter, achieving a 46% year-over-year increase. Organic revenue rose 23%, with orders growing 55% to $32.7 million. Backlog also hit a record $47.9 million. Net income climbed 16% to $2.5 million, with diluted EPS increasing 15% to $0.23. Despite supply chain challenges, the company anticipates 2022 revenue at the higher end of $110 million to $115 million. Demand remains strong in key markets, notably semiconductor and life sciences, bolstered by recent acquisitions.

inTEST Corporation (NYSE American: INTT) will announce its third quarter 2022 financial results before the market opens on November 4, 2022. Following the earnings release, the company will hold a conference call at 8:30 a.m. ET to discuss its financial performance, corporate strategies, and future outlook, with a question-and-answer session included. A replay of the call will be available until November 11, 2022, through a dedicated phone line and archived on the company's investor relations website.

inTEST Corporation (NYSE American: INTT) has announced the launch of its new SCAiLX Zoom Block cameras, featuring custom AI technology developed by Videology, a subsidiary of inTEST. This innovative product is a first-to-market solution aimed at several industrial applications, including traffic monitoring and machine vision. The SCAiLX cameras will be showcased at the upcoming Vision 2022 trade show in Stuttgart, Germany, from October 4-6, and are expected to be available in limited quantities in Q2 2023.

inTEST Corporation (NYSE American: INTT) has amended its loan agreement with M&T Bank, increasing the non-revolving delayed draw term loan facility from $25 million to $50.5 million. Following $20.5 million in borrowings in Q4 2021, the remaining available funding is now $30 million, with an extended maturity date of September 2027. The funds will support inTEST's growth strategy, including acquisitions. Current interest rates approximate 5.1%. CFO Duncan Gilmour highlighted this expansion enhances financial flexibility for executing their 5-Point Strategy.